is an innovative R&D and production company focusing on the pharmaceutical and health sectors.
Our vision is to develop innovative drugs with definite clinical values, to help disease-afflicted patients regain health.
Currently, we are focusing on four business areas, i.e., biologics, small molecules, synthetic biologics, and special traditional Chinese medicines (TCMs),
expanding our product R&D pipelines and innovating drugs for disease treatment to address unmet medical needs;
and we are striving to set up an extensive commercial network to facilitate the flow of quality drugs having reliable therapeutic effect across the world to help cure diseases.
* Data updated on December 31, 2021
Countries and regions covered
Number of R&D centers
Size of our subsidiaries
Establishment of manufacturing system
Listing on the main board of Shenzhen Stock Exchange
Establishment of Macromolecules R&D Center
Establishment of global business network
Establishment of Insulin Manufacturing Center